It has been suggested by several authors that the hepatotoxicity associated with the use of halothane represents an allergic reaction to the anmesthetic. The purpose of this paper is to describe briefly the characteristics of allergic reactions, to discuss the criteria which should be satisfied if untoward reactions to drugs are to be accepted as allergic reactions, and to examine the evidence conceming halothane-associated hepatitis in terms of these characteristics and criteria.
Allergic reactions which cause tissue damage have been classified by Gell & Coombs (1968) . Three types require the participation of antibody, whilst the fourth (cellular or delayed allergy) involves specifically modified mononuclear cells. All types require at least two contacts with allergen, the first initiating the allergy (i.e. sensitizing) and the second evoking the response. The interval between these two contacts must be sufficient to allow the development of antibody or modified cell. Allergies, especially Type IV which are T-lymphocyte-dependent, are persistent. Like immune responses, they are specific to a particular allergen but again, as with immunity, there may be a limited degree of cross-reactivity.
Unequivocal implication of drugs as causes of allergic reactions is rarely possible, the evidence often being largely circumstantial. Before a definite conclusion can be arrived at, there are certain criteria which must be applied:
(1) The drug, or a product of its metabolism, must be capable of forming covalent bonds with pro-tein. There is general agreement that small molecules (molecular weight less than 1000) can become antigenic only after combination with a larger molecule (in practice, with protein) and that this combination must be through the formation of covalent bonds. In other words the small molecule must be chemically reactive. Most, if not all, drugs do not possess this degree of reactivity but drug allergies can often be explained either by the demonstration of a reactive breakdown product (as with penicillin) or by the reasonable postulation of how such a reactive product might be formed (Davies 1958) . It is worth emphasizing that the reaction must be with protein: susceptibility of a reactive molecule to hydrolysis will pre-empt its capacity to form an antigen. Neither halothane nor its metabolites possess the required degree ofreactivity.
(2) The drug or a chemically closely related substance must have been given before. There are several reports of hepatotoxicity following the first anmsthesia with halothane (Mushin et al. 1971 , Paronetto & Popper 1970 .
(3) The allergy is usually long-lasting. This is not the case with the postulated sensitivity to halothane (Mushin et al. 1971 ).
(4) The symptoms are those of accepted allergies. Although the liver may be involved in allergic reactions, I know of no allergy to an exogenous allergen where the liver is the only organ exhibiting allergic manifestation. There are, however, long lists of drugs presumed to have caused allergic liver damage but the evidence is circumstantial and unconvincing (Popper et al. 1965 ).
(5) A skin test or some confirmative in vitro test is positive. There is one published report that lymphocytes from cases of halothane-associated hepatitis transform when exposed to halothane (Paronetto & Popper 1970 ). This finding is as yet unconfirmed and there are some puzzling features about the published data, in particular the appearance of hepatitis following a single expo-sure to halothane in 7 out of 15 patients, the transient nature of the response and the apparent cross-reactivity with methoxyflurane. The authors did not consider the possibility that the apparent increase in lymphocyte transformation was an over-compensation for a previous depressing effect of anesthesia on the transformation of a lymphocyte by nonspecific stimuli (Park & Brody 1971) . Finally there were only 2 control patients who were given halothane but did not develop jaundice.
It would seem therefore that the bulk of the available evidence indicates that, whatever the cause of halothane-associated hepatitis, it is not an allergic reaction to halothane. The possibility of a cause and effect relationship between halothane and postoperative liver dysfunction cannot be denied. We have, however, become increasingly uncomfortable about the quality of the evidence presented to substantiate the existence of 'halothane hepatitis'. In our view such evidence does not withstand careful scrutiny and is sometimes factually inaccurate (Simpson etal. 1971) .
The Anesthetics Unit at The London Hospital has been concerned with the problem of liver dysfunction after anmsthesia and surgery for some years (Strunin et al. 1966 ) and some eighteen months ago, in conjunction with a number of experts in specialized fields of immunology, virology and metabolism, set up a nationwide study of postoperative jaundice and liver dysfunction as it occurs. Some of the interim findings of this study will be referred to where pertinent. 'Present address: Angesthetic Department, King's College Hospital, London SE5 On this occasion it would be inappropriate not to discuss in greater depth the recent paper by Williams and his colleagues entitled 'Halothane hepatitis: A preventable disease?' (Sharpstone et al. 1971 ) and in particular to take issue with them on their statement that pyrexia of unknown origin or jaundice following a previous halothane anesthetic are mandatory reasons for subsequently withholding halothane.
The statement 'unexplained fever and jaundice in a specific patient might reasonably be con'sidered a contraindication to its subsequent use' was first issued as a caveat in the report on the US National Halothane Study (Bunker et al. 1966) and this viewpoint had been repeatedly reiterated.
However, over 60% of postoperative patients develop pyrexia (Klion, Schaffner & Paronetto 1969) which in more than 50% of such patients is unexplained (Dykes 1971) . Furthermore, postoperative pyrexia is as common after the use of other anesthetic agents as it is after halothane (Trey et al. 1968 ). Analysis of our first 90 cases of postoperative jaundice (Walton B, Simpson B R & Strunin L, unpublished data) shows that a variety of temperature patterns can be demonstrated after a previous anasthetic regardless of whether the cause is clear, e.g. massive hemolysis or stones in the common bile duct, or whether the cause is unexplained and therefore halothane might be suspected to be the cause. It should be noted particularly that a significant number of cases in the unexplained group were apyrexial after their previous halothane anesthetic (Table  1) . Is it not time for this myth to be acknowledged?
Similarly, in a retrospective survey in which 8 patients were found who had become jaundiced after halothane anvsthesia, 4 of these patients were again subjected to halothane aneesthesia and in no instance did the jaundice recur (Dykes et al. 1965) . From our interim data it would seem that when a patient who developed postoperative jaundice is submitted to further anTsthesia and surgery it is not possible to predict the effect on liver functionregardless of the anesthetic agent or combination of agents used. There is no logical
